Hadassah Medical Organization
Jerusalem, Israel
NCT Number: NCT02096523
The goal of this study is to identify the platelet defect responsible for the bleeding in families from our inherited platelet disorders Israeli-Palestinian registry. The investigators plan to characterize platelet proteome expression after removing high abundance proteins. The investigators will compare the proteome of sick and healthy members of families with inherited platelet disorders, and identify and validate structural proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet disorders. The investigators expect to discover new key findings that allow better understanding of human platelet function and allow better diagnosis and treatment of patients with inherited platelet function disorders.
Looking for future studies?
Notify Me3 year–85 year
All sexes
Interventional
Not applicable
Jerusalem, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2014-2015 (1 year)
Characterize platelet proteome expression profile
Time frame: 2015-2019 (4 years)
Analysis of platelet proteome of sick and healthy members of families with inherited platelet disorders
Time frame: 2017-2019 (2 years)
Identify and validate a panel of specific biomarkers candidates
Ela Shai
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.